US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Palvella Therapeutics

151.56

-1.3900-0.91%

Volume:136.36K

Turnover:20.88M

Market Cap:2.18B

PE:-30.94

High:155.59

Open:152.95

Low:150.76

Close:152.95

52wk High:161.38

52wk Low:51.38

Shares:14.41M

Float Shares:8.40M

Volume Ratio:0.87

T/O Rate:1.62%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-4.8978

EPS(LYR):-3.7076

ROE:-46.63%

ROA:-22.05%

PB:10.07

PE(LYR):-40.88

Loading ...

Overview Company News Filings

Calendar of U.S. Earnings Expected in the Week Ahead

Palvella Therapeutics announces Phase 2 DSAP trial start in H2 2026; Phase 3 SELVA study meets primary endpoint on mLM-IGA (p<0.001)

Palvella Therapeutics Highlights Continued Progress Across Rare Skin Disease Pipeline with Two Poster Presentations at the 2026 American Academy of Dermatology Annual Meeting

Has Palvella Therapeutics (PVLA) Run Too Far After Its 334% One-Year Surge?

Simply Wall St.

Palvella Therapeutics Is Maintained at Buy by HC Wainwright & Co.

Analysts Offer Insights on Healthcare Companies: Palvella Therapeutics (PVLA) and Neurogene (NGNE)

Palvella Therapeutics Inc. : H.c. Wainwright Raises Target Price to $270 From $255

THOMSON REUTERS

Palvella Therapeutics to host full-year 2025 financial results conference call and corporate update

Palvella Therapeutics appoints Jennifer J. McDonough as SVP of Market Access and Patient Services

Palvella Therapeutics (PVLA) Receives a Rating Update from a Top Analyst

Analysts Offer Insights on Healthcare Companies: Spectral AI (MDAI) and Palvella Therapeutics (PVLA)

Palvella Therapeutics Is Maintained at Buy by Chardan Capital

Palvella Therapeutics Secures European Patent No. 3565520 for QTORIN Rapamycin Anhydrous Gel

Palvella Therapeutics launches ‘BEYOND mLM’ disease awareness campaign

Palvella Therapeutics Launches "BEYOND mLM" Disease Awareness Campaign for Microcystic Lymphatic Malformations in Collaboration with Leading Lymphatic, Vascular, and Dermatology Nonprofit Organizations

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://au1.tigermoments.com/stock/PVLA/news?page=7"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PVLA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PVLA\",,,,,undefined,":{"symbol":"PVLA","market":"US","secType":"STK","nameCN":"Palvella Therapeutics","latestPrice":151.56,"timestamp":1788462179392,"preClose":152.95,"halted":0,"volume":136356,"delay":0,"changeRate":-0.009087937234390235,"floatShares":8398100,"shares":14408407,"eps":-4.897784,"marketStatus":"Trading","change":-1.39,"latestTime":"09-03 15:03:02 EDT","open":152.95,"high":155.59,"low":150.755,"amount":20882337.796320003,"amplitude":0.031612,"askPrice":152.01,"askSize":5,"bidPrice":151.5,"bidSize":2,"shortable":3,"etf":0,"ttmEps":-4.897784,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1788465600000},"marketStatusCode":2,"adr":0,"listingDate":1435636800000,"exchange":"NASDAQ","adjPreClose":152.95,"preHourTrading":{"tag":"盘前","latestPrice":157.63,"preClose":152.95,"latestTime":"09:11 EDT","volume":50,"amount":7800.5005,"timestamp":1788441074552,"change":4.68,"changeRate":0.030598,"amplitude":0.017195},"postHourTrading":{"tag":"盘后","latestPrice":152.95,"preClose":152.95,"latestTime":"19:30 EDT","volume":2627,"amount":401798.849,"timestamp":1788391804556,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.869394,"impliedVol":0.4972,"impliedVolPercentile":0.0397},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PVLA\",,,,,undefined,":{"symbol":"PVLA","floatShares":8398100,"roa":"-22.05%","roe":"-46.63%","lyrEps":-3.707588,"volumeRatio":0.869394,"shares":14408407,"dividePrice":0,"high":155.59,"amplitude":0.031612,"preClose":152.95,"low":150.755,"week52Low":51.38,"pbRate":"10.07","week52High":161.38,"institutionHeld":0,"latestPrice":151.56,"committee":-0.428571,"eps":-4.897784,"divideRate":0,"volume":136356,"delay":0,"ttmEps":-4.897784,"open":152.95,"prevYearClose":104.67,"prevWeekClose":149.97,"prevMonthClose":152.59,"prevQuarterClose":152.82,"fiveDayClose":150.33,"twentyDayClose":154.93,"sixtyDayClose":104.37},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PVLA\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-04","symbol":"PVLA","fiscalQuarterEnding":"2026/06","expectedEps":-1.16,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1785816000000,"reportTimeType":"pre","actualEps":-1.52},{"market":"US","date":"2026-05-07","symbol":"PVLA","fiscalQuarterEnding":"2026/03","expectedEps":-0.9,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1778126400000,"reportTimeType":"pre","actualEps":-1.2},{"market":"US","date":"2026-03-31","symbol":"PVLA","fiscalQuarterEnding":"2025/12","expectedEps":-0.95,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1774929600000,"reportTimeType":"pre","actualEps":-1.08},{"market":"US","date":"2025-11-11","symbol":"PVLA","fiscalQuarterEnding":"2025/09","expectedEps":-0.85,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1762837200000,"reportTimeType":"pre","actualEps":-1.03},{"market":"US","date":"2025-08-14","symbol":"PVLA","fiscalQuarterEnding":"2025/06","expectedEps":-0.78,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1755144000000,"reportTimeType":"pre","actualEps":-0.86}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PVLA\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PVLA\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.25,"buy":0.75,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.75,"analysts":16,"updateTime":1778558400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/PVLA\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"PVLA","date":"2026-09-02","current":-30.944607,"percent":0.269321,"low":-60.48704,"twenty":-36.891711,"median":-28.473318,"eighty":-10.993608,"high":46.119317,"avg":-19.85494,"sd":24.328676,"marketCap":2169185673},"quantilePoints":[{"date":"2024-12-20","current":19.163371,"twenty":19.017062,"median":19.163371,"eighty":20.457893,"marketCap":135216749},{"date":"2024-12-27","current":19.083855,"twenty":18.842127,"median":19.083855,"eighty":19.659551,"marketCap":134655684},{"date":"2025-01-03","current":21.071757,"twenty":18.969352,"median":19.083855,"eighty":19.907642,"marketCap":148682317},{"date":"2025-01-10","current":22.216788,"twenty":19.083855,"median":19.083855,"eighty":21.987782,"marketCap":156761658},{"date":"2025-01-17","current":20.960435,"twenty":19.083855,"median":20.523096,"eighty":21.13537,"marketCap":147896826},{"date":"2025-01-24","current":19.863113,"twenty":19.083855,"median":20.650322,"eighty":21.071757,"marketCap":140154124},{"date":"2025-01-31","current":20.674177,"twenty":19.083855,"median":20.658273,"eighty":21.151273,"marketCap":145876991},{"date":"2025-02-07","current":24.729496,"twenty":19.083855,"median":20.674177,"eighty":22.089563,"marketCap":174491323},{"date":"2025-02-14","current":31.090781,"twenty":19.083855,"median":20.912725,"eighty":23.46519,"marketCap":219376551},{"date":"2025-02-21","current":30.565975,"twenty":19.147468,"median":20.992241,"eighty":24.783567,"marketCap":215673520},{"date":"2025-02-28","current":30.804523,"twenty":19.723165,"median":21.111515,"eighty":29.913943,"marketCap":217356716},{"date":"2025-03-07","current":39.042387,"twenty":20.066674,"median":21.469337,"eighty":30.728188,"marketCap":275483086},{"date":"2025-03-14","current":43.678174,"twenty":20.34657,"median":22.439433,"eighty":31.793703,"marketCap":308193196},{"date":"2025-03-21","current":44.751641,"twenty":20.49288,"median":23.46519,"eighty":33.810231,"marketCap":315767578},{"date":"2025-03-28","current":44.688028,"twenty":20.604203,"median":24.292158,"eighty":40.654974,"marketCap":315318726},{"date":"2025-04-04","current":-15.155991,"twenty":19.723165,"median":23.46519,"eighty":39.236406,"marketCap":264229553},{"date":"2025-04-11","current":-13.752893,"twenty":19.083855,"median":22.439433,"eighty":38.266311,"marketCap":239767934},{"date":"2025-04-17","current":-15.396161,"twenty":19.00752,"median":21.77945,"eighty":36.545583,"marketCap":268416676},{"date":"2025-04-25","current":-16.047148,"twenty":-12.608925,"median":21.151273,"eighty":34.239617,"marketCap":279765986},{"date":"2025-05-02","current":-15.493342,"twenty":-14.192783,"median":21.008144,"eighty":33.36176,"marketCap":270110923},{"date":"2025-05-09","current":-14.42287,"twenty":-14.682214,"median":20.912725,"eighty":33.091405,"marketCap":251448313},{"date":"2025-05-16","current":-10.548775,"twenty":-14.614161,"median":20.674177,"eighty":32.251716,"marketCap":243497378},{"date":"2025-05-23","current":-10.577479,"twenty":-14.552086,"median":20.64237,"eighty":31.796884,"marketCap":244159956},{"date":"2025-05-30","current":-11.868448,"twenty":-14.483678,"median":20.515145,"eighty":31.510626,"marketCap":273959378},{"date":"2025-06-06","current":-11.250599,"twenty":-14.245514,"median":19.990339,"eighty":31.090781,"marketCap":259697570},{"date":"2025-06-13","current":-12.65393,"twenty":-13.898957,"median":19.083855,"eighty":30.976278,"marketCap":292090669},{"date":"2025-06-20","current":-9.82332,"twenty":-13.773118,"median":19.083855,"eighty":30.785439,"marketCap":226751689},{"date":"2025-06-27","current":-9.876005,"twenty":-13.751337,"median":19.083855,"eighty":30.680478,"marketCap":227967812},{"date":"2025-07-03","current":-11.552339,"twenty":-13.745115,"median":18.829404,"eighty":30.565975,"marketCap":266662639},{"date":"2025-07-11","current":-12.902986,"twenty":-13.143371,"median":-9.82332,"eighty":30.216104,"marketCap":297839615},{"date":"2025-07-18","current":-14.957693,"twenty":-13.611836,"median":-10.196903,"eighty":29.977556,"marketCap":345268417},{"date":"2025-07-25","current":-18.501942,"twenty":-13.979479,"median":-10.548775,"eighty":29.89804,"marketCap":427080338},{"date":"2025-08-01","current":-17.520089,"twenty":-14.593892,"median":-10.570486,"eighty":26.844623,"marketCap":404416225},{"date":"2025-08-08","current":-18.703103,"twenty":-14.909501,"median":-10.577479,"eighty":25.683689,"marketCap":431723718},{"date":"2025-08-15","current":-17.957373,"twenty":-15.155991,"median":-10.795594,"eighty":24.999851,"marketCap":509666156},{"date":"2025-08-22","current":-19.99406,"twenty":-15.421442,"median":-10.987175,"eighty":24.729496,"marketCap":567471411},{"date":"2025-08-29","current":-19.990163,"twenty":-15.528887,"median":-11.165181,"eighty":23.854819,"marketCap":567360814},{"date":"2025-09-05","current":-21.096831,"twenty":-16.235493,"median":-11.305678,"eighty":23.549477,"marketCap":598770263},{"date":"2025-09-12","current":-22.776317,"twenty":-17.271569,"median":-11.413443,"eighty":23.46678,"marketCap":646437419},{"date":"2025-09-19","current":-23.006223,"twenty":-17.715742,"median":-11.554734,"eighty":23.433384,"marketCap":652962621},{"date":"2025-09-26","current":-22.480166,"twenty":-18.057474,"median":-11.868448,"eighty":22.814749,"marketCap":638032073},{"date":"2025-10-03","current":-24.405145,"twenty":-18.52589,"median":-11.961844,"eighty":22.305846,"marketCap":692666818},{"date":"2025-10-10","current":-27.312096,"twenty":-18.938434,"median":-12.127082,"eighty":22.115008,"marketCap":775171919},{"date":"2025-10-17","current":-28.500595,"twenty":-19.602341,"median":-12.457671,"eighty":21.593382,"marketCap":808903898},{"date":"2025-10-24","current":-27.783599,"twenty":-20.103168,"median":-12.65393,"eighty":21.227608,"marketCap":788554114},{"date":"2025-10-31","current":-30.558062,"twenty":-20.870432,"median":-12.719639,"eighty":21.154454,"marketCap":867298929},{"date":"2025-11-07","current":-30.639894,"twenty":-21.250362,"median":-12.96286,"eighty":21.08766,"marketCap":869621458},{"date":"2025-11-14","current":-28.915921,"twenty":-22.006325,"median":-13.231068,"eighty":21.033589,"marketCap":952837445},{"date":"2025-11-21","current":-32.881534,"twenty":-22.215189,"median":-13.745115,"eighty":20.998602,"marketCap":1083512294},{"date":"2025-11-28","current":-36.922579,"twenty":-22.816843,"median":-13.778174,"eighty":20.973157,"marketCap":1216672807},{"date":"2025-12-05","current":-33.693335,"twenty":-23.242364,"median":-14.278382,"eighty":20.931809,"marketCap":1110262762},{"date":"2025-12-12","current":-34.763763,"twenty":-24.512694,"median":-14.593892,"eighty":20.769596,"marketCap":1145535502},{"date":"2025-12-19","current":-34.569792,"twenty":-27.267674,"median":-14.831115,"eighty":20.674177,"marketCap":1139143797},{"date":"2025-12-26","current":-38.014559,"twenty":-27.693195,"median":-14.933597,"eighty":20.674177,"marketCap":1252655736},{"date":"2026-01-02","current":-37.597882,"twenty":-28.489684,"median":-15.118842,"eighty":20.670996,"marketCap":1238925408},{"date":"2026-01-09","current":-34.979285,"twenty":-28.647112,"median":-15.258978,"eighty":20.655092,"marketCap":1152637396},{"date":"2026-01-16","current":-37.350031,"twenty":-29.232399,"median":-15.408801,"eighty":20.639189,"marketCap":1230758230},{"date":"2026-01-23","current":-33.075504,"twenty":-29.325414,"median":-15.443563,"eighty":20.626467,"marketCap":1089903999},{"date":"2026-01-30","current":-29.418807,"twenty":-29.517639,"median":-15.528887,"eighty":20.515145,"marketCap":969408531},{"date":"2026-02-06","current":-27.453961,"twenty":-29.48062,"median":-16.091391,"eighty":20.403822,"marketCap":904662930},{"date":"2026-02-13","current":-29.461912,"twenty":-29.48062,"median":-17.007828,"eighty":20.117564,"marketCap":970828909},{"date":"2026-02-20","current":-29.573265,"twenty":-29.488024,"median":-17.242297,"eighty":19.914003,"marketCap":974498221},{"date":"2026-02-27","current":-60.48704,"twenty":-29.707799,"median":-17.512905,"eighty":19.303319,"marketCap":1993168926},{"date":"2026-03-06","current":-55.02714,"twenty":-30.090518,"median":-17.81704,"eighty":19.099758,"marketCap":1813254325},{"date":"2026-03-13","current":-55.699943,"twenty":-30.574428,"median":-17.963839,"eighty":19.083855,"marketCap":1835424534},{"date":"2026-03-20","current":-46.447881,"twenty":-31.137829,"median":-18.431476,"eighty":19.083855,"marketCap":1530550575},{"date":"2026-03-27","current":-47.956591,"twenty":-32.06614,"median":-18.561811,"eighty":19.083855,"marketCap":1580265588},{"date":"2026-04-02","current":-41.305964,"twenty":-32.945472,"median":-18.707892,"eighty":19.083855,"marketCap":1723078270},{"date":"2026-04-10","current":-44.675498,"twenty":-33.393759,"median":-19.095844,"eighty":19.083855,"marketCap":1863638401},{"date":"2026-04-17","current":-42.609857,"twenty":-34.004406,"median":-19.561706,"eighty":18.969352,"marketCap":1777470174},{"date":"2026-04-24","current":-43.594639,"twenty":-34.788907,"median":-19.977117,"eighty":18.816681,"marketCap":1818550375},{"date":"2026-05-01","current":-44.030414,"twenty":-35.208457,"median":-20.266831,"eighty":18.756249,"marketCap":1836728722},{"date":"2026-05-08","current":-32.885673,"twenty":-35.663927,"median":-20.816267,"eighty":1.605963,"marketCap":1621165018},{"date":"2026-05-15","current":-34.614036,"twenty":-35.663927,"median":-21.021819,"eighty":-9.854931,"marketCap":1706368150},{"date":"2026-05-22","current":-33.726646,"twenty":-35.536117,"median":-21.24101,"eighty":-10.054175,"marketCap":1662622476},{"date":"2026-05-29","current":-33.709189,"twenty":-35.477208,"median":-21.439742,"eighty":-10.192113,"marketCap":1661761905},{"date":"2026-06-05","current":-33.406604,"twenty":-35.361812,"median":-22.020353,"eighty":-10.267821,"marketCap":1646845348},{"date":"2026-06-12","current":-30.951006,"twenty":-35.258528,"median":-22.098288,"eighty":-10.422477,"marketCap":1525791744},{"date":"2026-06-18","current":-32.769429,"twenty":-35.21133,"median":-22.480166,"eighty":-10.551201,"marketCap":1615434519},{"date":"2026-06-26","current":-39.627064,"twenty":-35.273781,"median":-22.826974,"eighty":-10.561865,"marketCap":1953495352},{"date":"2026-07-02","current":-40.226416,"twenty":-35.557603,"median":-22.973101,"eighty":-10.565696,"marketCap":1983041611},{"date":"2026-07-10","current":-43.944726,"twenty":-36.020976,"median":-23.275097,"eighty":-10.575275,"marketCap":2166343157},{"date":"2026-07-17","current":-42.993327,"twenty":-36.290379,"median":-24.416835,"eighty":-10.577479,"marketCap":2119442057},{"date":"2026-07-24","current":-41.665152,"twenty":-36.922579,"median":-25.632611,"eighty":-10.577479,"marketCap":2053966975},{"date":"2026-07-31","current":-43.697421,"twenty":-37.223591,"median":-27.238059,"eighty":-10.749704,"marketCap":2154151740},{"date":"2026-08-07","current":-36.182159,"twenty":-37.223591,"median":-27.449273,"eighty":-10.795027,"marketCap":2232294496},{"date":"2026-08-14","current":-36.560492,"twenty":-37.14313,"median":-27.55759,"eighty":-10.795594,"marketCap":2255636115},{"date":"2026-08-21","current":-33.297956,"twenty":-36.964247,"median":-27.969419,"eighty":-10.845405,"marketCap":2054350670},{"date":"2026-08-28","current":-35.107881,"twenty":-36.922579,"median":-28.427404,"eighty":-10.961312,"marketCap":2166015824},{"date":"2026-09-02","current":-35.159259,"twenty":-36.891711,"median":-28.473318,"eighty":-10.993608,"marketCap":2169185673}],"updateTime":1788462182205},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PVLA\",pageSize:20,pageCount:7,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2623315199","title":"Calendar of U.S. Earnings Expected in the Week Ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=2623315199","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623315199?lang=en_us&edition=fundamental","pubTime":"2026-03-30 18:00","pubTimestamp":1774864800,"startTime":"0","endTime":"0","summary":"Major companies tentatively scheduled to report quarterly earnings in the week ahead, with earnings estimates provided by FactSet Research Systems Inc.·INmune Bio Inc.                                 4Q      (.26)  4:05 PM. ·Dave & Buster                                   4Q       .39   4:05 PM. ·NIKE Class B                                     3Q       .29   4:15 PM","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BEEM","CALM","BITF","IMNN","PROP","PVLA","PVH","RH","MKC","NKE","RNXT","NKLR","PRPL","APOG","SGMO","AIRO","FC","PENG","DMAC","CAG","PRGS","FDS","NEOG","LNN","KEEL","AIRJ","MSM","BCAX","PLAY","MKC.V","SGML","NGEN","ANGO","BYND","INV","NMRA","CRDL","AEHR","PHR","BHST","BTBT","AURA","INMB","JILL","MAZE","AYI","NCNO","BIRD","BNZI","LW","NNOX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622783458","title":"Palvella Therapeutics announces Phase 2 DSAP trial start in H2 2026; Phase 3 SELVA study meets primary endpoint on mLM-IGA (p<0.001)","url":"https://stock-news.laohu8.com/highlight/detail?id=2622783458","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622783458?lang=en_us&edition=fundamental","pubTime":"2026-03-27 22:30","pubTimestamp":1774621836,"startTime":"0","endTime":"0","summary":"Palvella Therapeutics announces Phase 2 DSAP trial start in H2 2026; Phase 3 SELVA study meets primary endpoint on mLM-IGA . Palvella reported that it will present two posters at the 2026 American Academy of Dermatology Annual Meeting, including data on QTORIN rapamycin topical formulation work and an interview study on porokeratosis burden.In the QTORIN rapamycin poster, the company described its Phase 3 SELVA study in microcystic lymphatic malformations as having met the primary endpoint on mLM-IGA  and reported rapamycin systemic levels below 2 ng/mL at all measured timepoints.The porokeratosis poster summarizes 10 qualitative interviews conducted with patients (n=9) and a caregiver (n=1) to assess physical, psychosocial, cancer-related, and treatment burdens.Palvella said it plans to start a Phase 2 trial of QTORIN pitavastatin for disseminated superficial actinic porokeratosis in the second half of 2026.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260327:nNDL37xXwV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BN0W2V16.EUR","IE00BN0W2W23.USD","IE00BKPKM429.USD","LU2210149790.SGD","BK4588","LU2095319765.USD","BK4112","SG9999014021.USD","SG9999014013.SGD","LU2210150020.SGD","LU0314104364.USD","IE00B3QW5Z07.USD","IE00B64PRP62.GBP","SG9999014005.SGD","SG9999014039.USD","NDAQ","BK4139","BK4585","IE00BN0W2T93.GBP","IE00BGHQF748.EUR","PVLA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622878063","title":"Palvella Therapeutics Highlights Continued Progress Across Rare Skin Disease Pipeline with Two Poster Presentations at the 2026 American Academy of Dermatology Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2622878063","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622878063?lang=en_us&edition=fundamental","pubTime":"2026-03-27 22:30","pubTimestamp":1774621800,"startTime":"0","endTime":"0","summary":"Poster #76954 highlights QTORIN rapamycin’s single phase anhydrous gel formulation designed to optimize dermal bioavailability of rapamycin for mTOR-driven skin diseases while overcoming the crystalli","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/03/27/3263839/0/en/Palvella-Therapeutics-Highlights-Continued-Progress-Across-Rare-Skin-Disease-Pipeline-with-Two-Poster-Presentations-at-the-2026-American-Academy-of-Dermatology-Annual-Meeting.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4588","LU2065732104.USD","BK4097","BK4585","PVLA","LABU","BK4107","PRGS","AFG","BK4117"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622887346","title":"Has Palvella Therapeutics (PVLA) Run Too Far After Its 334% One-Year Surge?","url":"https://stock-news.laohu8.com/highlight/detail?id=2622887346","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622887346?lang=en_us&edition=fundamental","pubTime":"2026-03-26 10:08","pubTimestamp":1774490920,"startTime":"0","endTime":"0","summary":"Investors may be wondering whether Palvella Therapeutics at around US$120 a share is still offering value, or if most of the easy gains are already on the table.\nThe stock is up 5.7% over the last 7 days and 20.1% year to date, with a very strong 333.7% return over the past year that may indicate shifting expectations and risk perceptions.\nRecent attention around Palvella Therapeutics has focused on its position in the biotech space and how the market is reassessing smaller, high potential...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-pvla/palvella-therapeutics/news/has-palvella-therapeutics-pvla-run-too-far-after-its-334-one","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-pvla/palvella-therapeutics/news/has-palvella-therapeutics-pvla-run-too-far-after-its-334-one","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4139","PVLA","DCF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621909600","title":"Palvella Therapeutics Is Maintained at Buy by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2621909600","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621909600?lang=en_us&edition=fundamental","pubTime":"2026-03-24 23:32","pubTimestamp":1774366320,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/PVLA/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 24, 2026 11:32 ET (15:32 GMT)","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PVLA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621096171","title":"Analysts Offer Insights on Healthcare Companies: Palvella Therapeutics (PVLA) and Neurogene (NGNE)","url":"https://stock-news.laohu8.com/highlight/detail?id=2621096171","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621096171?lang=en_us&edition=fundamental","pubTime":"2026-03-24 23:10","pubTimestamp":1774365009,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Palvella Therapeutics (PVLA) and Neurogene (NGNE) wi...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-palvella-therapeutics-pvla-and-neurogene-ngne-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-palvella-therapeutics-pvla-and-neurogene-ngne-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PVLA","LU0128526141.USD","BK4581","LU0029874061.USD","BK4137","XLV","NGNE","LABU","BK4588","HCSG","BK4585","BK4139","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621095221","title":"Palvella Therapeutics Inc. : H.c. Wainwright Raises Target Price to $270 From $255","url":"https://stock-news.laohu8.com/highlight/detail?id=2621095221","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621095221?lang=en_us&edition=fundamental","pubTime":"2026-03-24 22:54","pubTimestamp":1774364084,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260324:nAZN4SMVL9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PVLA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621069070","title":"Palvella Therapeutics to host full-year 2025 financial results conference call and corporate update","url":"https://stock-news.laohu8.com/highlight/detail?id=2621069070","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621069070?lang=en_us&edition=fundamental","pubTime":"2026-03-24 19:31","pubTimestamp":1774351885,"startTime":"0","endTime":"0","summary":"Palvella will report full year 2025 financial results before market open on March 31, 2026.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260324:nNDL1Zwf9n:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4588","SG9999014039.USD","SG9999014005.SGD","LU0314104364.USD","NDAQ","PVLA","IE00B3QW5Z07.USD","IE00BN0W2V16.EUR","LU2210149790.SGD","IE00BGHQF748.EUR","SG9999014013.SGD","IE00BKPKM429.USD","BK4585","IE00B64PRP62.GBP","IE00BN0W2W23.USD","LU2210150020.SGD","BK4112","SG9999014021.USD","IE00BN0W2T93.GBP","LU2095319765.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621777076","title":"Palvella Therapeutics appoints Jennifer J. McDonough as SVP of Market Access and Patient Services","url":"https://stock-news.laohu8.com/highlight/detail?id=2621777076","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621777076?lang=en_us&edition=fundamental","pubTime":"2026-03-23 19:31","pubTimestamp":1774265483,"startTime":"0","endTime":"0","summary":"Palvella appointed Jennifer J. McDonough as Senior Vice President of Market Access and Patient Services.McDonough most recently served at Krystal Biotech as Senior Vice President of Patient Access, Analytics & Operations from 2021 to 2026.At Krystal Biotech, she supported the U.S. launch of VYJUVEK following FDA approval in 2023 and helped grow annual sales to USD 389 million by 2025.Her prior roles include senior leadership positions at Strongbridge Biopharma, Cencora, EMD Serono, and CVS Health.In her new role, McDonough will oversee payer engagement, patient support, specialty distribution, and access strategy for Palvella’s QTORIN programs.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260323:nNDL8x7vBR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0289739699.SGD","LU2237957811.SGD","LU1699723380.USD","SG9999014021.USD","LU2324357040.USD","SG9999014039.USD","XERS","SG9999014013.SGD","BK4139","LU1983299246.USD","LU0006061336.USD","LU0208291251.USD","LU1084165304.USD","IE00BN0W2W23.USD","LU0070302665.USD","BK4588","BK4175","IE00BSNM7G36.USD","LU2095319765.USD","BK4550","SGXZ23171101.USD","PVLA","CVS","LU0432979614.USD","COR","IE00BZ1G4Q59.USD","LU1261432733.SGD","LU1571399168.USD","NDAQ","IE00B19Z3581.USD","IE00BN0W2V16.EUR","IE00B19Z3B42.SGD","LU1119994496.HKD","IE00B3QW5Z07.USD","IE00BKVL7J92.USD","BK4504","LU0061475181.USD","LU2210149790.SGD","IE00BGHQF748.EUR","LU0320765489.SGD","LU2210150020.SGD","BK4585","LU0314104364.USD","SG9999014005.SGD","SG9999004303.SGD","BK4084","KRYS","BK4007","IE0002270589.USD","BK4529"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621379388","title":"Palvella Therapeutics (PVLA) Receives a Rating Update from a Top Analyst","url":"https://stock-news.laohu8.com/highlight/detail?id=2621379388","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621379388?lang=en_us&edition=fundamental","pubTime":"2026-03-21 22:55","pubTimestamp":1774104930,"startTime":"0","endTime":"0","summary":"In a report released today, Sam Slutsky from LifeSci Capital maintained a Buy rating on Palvella Therapeutics, with a price target of $222.00. Slut...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/palvella-therapeutics-pvla-receives-a-rating-update-from-a-top-analyst-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/palvella-therapeutics-pvla-receives-a-rating-update-from-a-top-analyst-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PVLA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620268952","title":"Analysts Offer Insights on Healthcare Companies: Spectral AI (MDAI) and Palvella Therapeutics (PVLA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2620268952","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620268952?lang=en_us&edition=fundamental","pubTime":"2026-03-19 21:30","pubTimestamp":1773927038,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Spectral AI (MDAI) and Palvella Therapeutics (PVLA) ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-spectral-ai-mdai-and-palvella-therapeutics-pvla-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-spectral-ai-mdai-and-palvella-therapeutics-pvla-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PVLA","BK4543","BK4581","LU0029874061.USD","BK4528","HCSG","XBI","BK4137","BK4588","MDAI","BK4139","AIYY","AI","BK4082","LU0128526141.USD","BK4023","BK4587","XLV","BK4585","BK4551","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620496338","title":"Palvella Therapeutics Is Maintained at Buy by Chardan Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2620496338","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620496338?lang=en_us&edition=fundamental","pubTime":"2026-03-17 03:26","pubTimestamp":1773689160,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/PVLA/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 16, 2026 15:26 ET (19:26 GMT)","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PVLA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619457035","title":"Palvella Therapeutics Secures European Patent No. 3565520 for QTORIN Rapamycin Anhydrous Gel","url":"https://stock-news.laohu8.com/highlight/detail?id=2619457035","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619457035?lang=en_us&edition=fundamental","pubTime":"2026-03-16 19:31","pubTimestamp":1773660685,"startTime":"0","endTime":"0","summary":"Palvella said the European Patent Office issued European Patent No. 3565520 covering QTORIN 3.9% rapamycin anhydrous gel and related methods of use. The patent includes claims for anhydrous topical compositions of rapamycin and treatment of microcystic lymphatic malformations and venous malformations. Palvella said the patent protection extends into 2038. The company said QTORIN rapamycin previously received European Orphan Drug Designation for microcystic lymphatic malformations, which may provide 10 years of market exclusivity in the EU upon approval.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260316:nNDL2PNLHh:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PVLA","NDAQ","LU0314104364.USD","IE00BN0W2V16.EUR","IE00BN0W2W23.USD","IE00BN0W2T93.GBP","LU2095319765.USD","SG9999014021.USD","IE00BKPKM429.USD","LU2210150020.SGD","BK4588","LU2210149790.SGD","SG9999014013.SGD","IE00BGHQF748.EUR","IE00B64PRP62.GBP","SG9999014005.SGD","IE00B3QW5Z07.USD","SG9999014039.USD","BK4585","BK4112","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618937873","title":"Palvella Therapeutics launches ‘BEYOND mLM’ disease awareness campaign","url":"https://stock-news.laohu8.com/highlight/detail?id=2618937873","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618937873?lang=en_us&edition=fundamental","pubTime":"2026-03-10 19:40","pubTimestamp":1773142824,"startTime":"0","endTime":"0","summary":"Palvella Therapeutics (PVLA) announced the launch of “BEYOND mLM,” a new disease state awareness campaign and website designed to educate patients,...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/palvella-therapeutics-launches-beyond-mlm-disease-awareness-campaign-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/palvella-therapeutics-launches-beyond-mlm-disease-awareness-campaign-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PVLA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618793030","title":"Palvella Therapeutics Launches \"BEYOND mLM\" Disease Awareness Campaign for Microcystic Lymphatic Malformations in Collaboration with Leading Lymphatic, Vascular, and Dermatology Nonprofit Organizations","url":"https://stock-news.laohu8.com/highlight/detail?id=2618793030","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618793030?lang=en_us&edition=fundamental","pubTime":"2026-03-10 19:30","pubTimestamp":1773142200,"startTime":"0","endTime":"0","summary":"BEYONDmLM.com campaign designed to educate, engage, and empower patients, caregivers, and healthcare professionals Campaign developed and launched in close collaboration with leading nonprofit organiz","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/03/10/3252673/0/en/Palvella-Therapeutics-Launches-BEYOND-mLM-Disease-Awareness-Campaign-for-Microcystic-Lymphatic-Malformations-in-Collaboration-with-Leading-Lymphatic-Vascular-and-Dermatology-Nonpro.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","PVLA"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":7,"pageCount":7,"totalSize":135,"code":"91000000","status":"200"}]}}